Detalles de la búsqueda
1.
Using prednisolone and cortisol assays to assess adherence in oral corticosteroid dependant asthma: An analysis of test-retest repeatability.
Pulm Pharmacol Ther
; 64: 101951, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33045343
2.
Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics: an interventional open-label study.
Thorax
; 74(8): 806-809, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30940770
3.
Agreement Between Rectosigmoidoscopy and Colonoscopy Analyses of Disease Activity and Healing in Patients With Ulcerative Colitis.
Gastroenterology
; 150(2): 389-95.e3, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26526713
4.
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.
Lancet Gastroenterol Hepatol
; 7(1): 17-27, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34798036
5.
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Lancet Gastroenterol Hepatol
; 7(1): 28-37, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34798037
6.
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.
Lancet Gastroenterol Hepatol
; 7(2): 118-127, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34798038
7.
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Lancet Gastroenterol Hepatol
; 7(2): 128-140, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34798039
8.
Dual targeting of lymphocyte homing and retention through α4ß7 and αEß7 inhibition in inflammatory bowel disease.
Cell Rep Med
; 2(8): 100381, 2021 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34467254
9.
Assessment of Correlation Between Early and Late Efficacy Endpoints to Identify Potential Surrogacy Relationships in Non-Hodgkin Lymphoma: a Literature-Based Meta-analysis of 108 Phase II and Phase III Studies.
AAPS J
; 19(3): 669-681, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28224402
10.
A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia.
Leuk Lymphoma
; 56(10): 2826-33, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25797560
11.
Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study.
J Clin Oncol
; 33(30): 3467-74, 2015 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26282650
12.
Prosthesis size and long-term survival after aortic valve replacement.
J Thorac Cardiovasc Surg
; 126(3): 783-96, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-14502155
13.
Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma.
Leuk Lymphoma
; 55(10): 2335-40, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24471908
Resultados
1 -
13
de 13
1
Próxima >
>>